BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22964596)

  • 1. Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis.
    Gertz MA; Lacy MQ; Dispenzieri A; Kumar SK; Dingli D; Leung N; Hogan WJ; Buadi FK; Hayman SR
    Bone Marrow Transplant; 2013 Apr; 48(4):557-61. PubMed ID: 22964596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis.
    Kristen AV; Rosenberg M; Lindenmaier D; Merkle C; Steen H; Andre F; Schönland SO; Schnabel PA; Schuster T; Röcken C; Giannitsis E; Katus HA; Frey N
    Amyloid; 2014 Sep; 21(3):202-10. PubMed ID: 25007036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous stem cell transplant is an effective therapy for carefully selected patients with AL amyloidosis: experience of a single institution.
    Jimenez-Zepeda VH; Franke N; Reece DE; Trudel S; Chen C; Delgado DH; Winter A; Mikhael JR; Tiedemann R; Kukreti V
    Br J Haematol; 2014 Mar; 164(5):722-8. PubMed ID: 24266428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis.
    Dispenzieri A; Gertz MA; Kyle RA; Lacy MQ; Burritt MF; Therneau TM; Greipp PR; Witzig TE; Lust JA; Rajkumar SV; Fonseca R; Zeldenrust SR; McGregor CG; Jaffe AS
    J Clin Oncol; 2004 Sep; 22(18):3751-7. PubMed ID: 15365071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD.
    Chang CL; Robinson SC; Mills GD; Sullivan GD; Karalus NC; McLachlan JD; Hancox RJ
    Thorax; 2011 Sep; 66(9):764-8. PubMed ID: 21474497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D; Flu WJ; Hoeks SE; Galal W; Dunkelgrun M; Boersma E; Kuijper R; van Kuijk JP; Winkel TA; Schouten O; Bax JJ; Poldermans D
    Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum uric acid: novel prognostic factor in primary systemic amyloidosis.
    Kumar S; Dispenzieri A; Lacy MQ; Hayman SR; Leung N; Zeldenrust SR; Buadi FK; Kyle RA; Rajkumar SV; Gertz MA
    Mayo Clin Proc; 2008 Mar; 83(3):297-303. PubMed ID: 18315995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
    Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M
    Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved.
    Al Saleh AS; Sidiqi MH; Muchtar E; Dispenzieri A; Buadi FK; Dingli D; Lacy MQ; Warsame RM; Gonsalves WI; Kourelis TV; Hogan WJ; Hayman SR; Kapoor P; Kumar SK; Gertz MA
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1520-1525. PubMed ID: 31054986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis.
    Lilleness B; Ruberg FL; Mussinelli R; Doros G; Sanchorawala V
    Blood; 2019 Jan; 133(3):215-223. PubMed ID: 30333122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements.
    Kumar S; Dispenzieri A; Lacy MQ; Hayman SR; Buadi FK; Colby C; Laumann K; Zeldenrust SR; Leung N; Dingli D; Greipp PR; Lust JA; Russell SJ; Kyle RA; Rajkumar SV; Gertz MA
    J Clin Oncol; 2012 Mar; 30(9):989-95. PubMed ID: 22331953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers.
    Buss SJ; Emami M; Mereles D; Korosoglou G; Kristen AV; Voss A; Schellberg D; Zugck C; Galuschky C; Giannitsis E; Hegenbart U; Ho AD; Katus HA; Schonland SO; Hardt SE
    J Am Coll Cardiol; 2012 Sep; 60(12):1067-76. PubMed ID: 22883634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous stem cell transplantation in primary systemic amyloidosis: the impact of selection criteria on outcome.
    Mollee PN; Wechalekar AD; Pereira DL; Franke N; Reece D; Chen C; Stewart AK
    Bone Marrow Transplant; 2004 Feb; 33(3):271-7. PubMed ID: 14647248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating N-terminal pro-brain natriuretic peptide and cardiac troponin T in chronic dialysis patients.
    Leowattana W; Ong-Ajyooth L; Taruangsri P; Pokum S
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S52-8. PubMed ID: 12866769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure.
    Rothenburger M; Wichter T; Schmid C; Stypmann J; Tjan TD; Berendes E; Etz C; Pioux A; Löher A; Wenzelburger F; Drees G; Hoffmeier A; Breithardt G; Scheld HH
    J Heart Lung Transplant; 2004 Oct; 23(10):1189-97. PubMed ID: 15477114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure.
    Perna ER; Macin SM; Cimbaro Canella JP; Szyszko A; Franciosi V; Vargas Morales W; Bayol AP; Kriskovich JO; Medina F; Gonzalez Arjol B; Brizuela M
    J Heart Lung Transplant; 2006 Oct; 25(10):1230-40. PubMed ID: 17045936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year survival after autologous stem cell transplantation for immunoglobulin light chain amyloidosis.
    Cordes S; Dispenzieri A; Lacy MQ; Hayman SR; Buadi FK; Dingli D; Kumar SK; Hogan WJ; Gertz MA
    Cancer; 2012 Dec; 118(24):6105-9. PubMed ID: 22707405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac biomarkers and survival in haemodialysis patients.
    Sommerer C; Beimler J; Schwenger V; Heckele N; Katus HA; Giannitsis E; Zeier M
    Eur J Clin Invest; 2007 May; 37(5):350-6. PubMed ID: 17461980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal pro-brain natriuretic peptide and angiotensin-converting enzyme-2 levels and their association with postoperative cardiac complications after emergency orthopedic surgery.
    Chong CP; Lim WK; Velkoska E; van Gaal WJ; Ryan JE; Savige J; Burrell LM
    Am J Cardiol; 2012 May; 109(9):1365-73. PubMed ID: 22381157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.